Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Healthcare Triangle, Inc. focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare. The company primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $31.3M | $35.3M | $45.9M | $33.2M | $11.7M | $13.9M |
| Gross profit | — | — | — | $1.1B | $1.1B | $1.2B |
| Operating income | $1.2M | -$5.4M | -$16.3M | -$7.7M | -$4.8M | -$9.8M |
| Net income | $2.4M | -$5.9M | -$14.4M | -$8.7M | -$6.0M | -$9.5M |
| Diluted EPS | $0.08 | -$0.20 | -$3.88 | -$2.08 | -$16,909.30 | -$152.30 |
| Operating cash flow | -$734,675.00 | -$7.1M | -$5.4M | -$2.2M | -$1.1M | -$16.5M |
| Free cash flow | — | — | -$5.4M | -$2.2M | — | -$16.5M |
| Gross margin | — | — | — | 3222.6% | 9148.4% | 8890.6% |
| Operating margin | 3.8% | -15.2% | -35.6% | -23.2% | -40.6% | -70.5% |
| Net margin | 7.5% | -16.9% | -31.3% | -26.2% | -51.0% | -68.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M | $2.4M | $2.2M | $3.7M | $3.6M | $3.5M | $3.1M | $9.9M |
| Gross profit | $0.00 | $0.00 | $0.00 | $1.1B | $0.00 | $0.00 | $165.0M | — |
| Operating income | -$1.4M | -$1.2M | -$493,000.00 | -$1.4M | -$1.4M | -$2.6M | -$4.4M | -$3.6M |
| Net income | -$1.5M | -$1.2M | -$1.3M | -$1.7M | -$1.4M | -$1.9M | -$4.5M | -$6.2M |
| Diluted EPS | -$70.72 | -$54.78 | -$16,783.38 | -$0.17 | -$0.58 | -$0.42 | -$151.13 | -$6.81 |
| Operating cash flow | -$935,000.00 | $715,000.00 | -$811,000.00 | -$5.6M | -$2.6M | -$1.5M | -$6.8M | -$6.9M |
| Free cash flow | — | — | — | — | — | -$1.5M | — | -$6.9M |
| Gross margin | 0.0% | 0.0% | 0.0% | 28887.7% | 0.0% | 0.0% | 5254.8% | — |
| Operating margin | -46.2% | -48.4% | -22.5% | -37.7% | -38.2% | -74.3% | -141.4% | -36.8% |
| Net margin | -50.6% | -51.8% | -61.6% | -45.9% | -38.4% | -54.6% | -143.4% | -62.9% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.